JAB Insurance stepped in with a deal to buy New York based Columbian Mutual Life and its Illinois arm Columbian Life, both still stuck in state rehabilitation.
The agreement sits at the centre of the proposed CML rehab plan and brings fresh capital meant to give policyholders a steady, permanent landing spot.
Courts overseeing Columbian Financial Group’s rehab still need to sign off.
The company said the structure came together with policyholder protection front and centre, built closely with the New York Liquidation Bureau on the CML side and the Illinois Office of the Special Deputy on the CLIC side.
Those agencies steer the rehab of insolvent insurers, and this one needed plenty of steering. JAB kept the financial terms quiet, and no one picked up the phone for comment.
Regulators for both CML and CLIC pushed for a rehab path through JAB, framing it as a better route than liquidation.
JAB pitched itself as a strategic buyer with permanent capital and a solid track record across the insurance value chain. We think that framing checks out, even if the market’s a bit jittery.
Bhalla, JAB Insurance’s executive chair, said the mission stays simple: keep the promises made to policyholders and anchor long term security. He added that the firm expects to invest in the insurers’ future and fold both customers and employees into the broader JAB setup.
He also tipped his hat to NYLB and OSD for helping stitch together a workable deal, which sounded slightly folksy but also genuine.
New York’s Department of Financial Services moved in earlier. Superintendent Adrienne Harris in 2024 asked a state court for control of Columbian Mutual after the group’s website flagged concerns about the company’s financial condition.
That request followed a petition lodged in Broome County Supreme Court. The sequence came roughly a month after Columbian Mutual said it would cut 26% of its New York workforce starting early September, a detail that hinted at deeper strain.
The whole situation feels like a slow moving collapse interrupted by a buyer with enough capital to stop the bleeding. Whether rehab plus acquisition delivers the long term recovery regulators want is still open, hanging, but at least there’s a path now.
